Drug Database
Back to search

Netherlands· NL-fe51f8d22b90

Empagliflozine/Metformine HCl HCS 12,5 mg/850 mg filmomhulde tabletten

A metformin and empagliflozin product containing empagliflozine + metforminehydrochloride, registered in Netherlands by HCS B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC A10BD20

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedEmpagliflozine/Metformine HCl HCS 12,…ATCA10BD20REGISTER NO.NL-fe51f8d22b90PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about empagliflozine + metforminehydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Metformin and empagliflozin is registered in 13 of 19 countries.

Countries holding a registration under ATC A10BD20 (metformin and empagliflozin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search metformin and empagliflozin products by name

Metformin and empagliflozin · ATC A10BD20

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
EMPAGLIFLOZINE + METFORMINEHYDROCHLORIDE
Manufacturer
HCS B.V.
Country
Netherlands (NL)
ATC code
A10BD20
ATC class
Metformin and empagliflozin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    134806

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Metformin and empagliflozin in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All metformin and empagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Empagliflozin/Metformin Hcs
  • Belgium · Empagliflozine/Metformine Hcl Hcs
  • Bulgaria · Empafel Met 5 Mg/850 Mg, Емпафел Мет
  • Cyprus · Empagliflozin/Metformin Tad
  • Czechia · Mempoglyn
  • Denmark · Empagliflozin/Metformin Krka
  • Estonia · Mempoglyn
  • Spain · Empagliflozina/Metformina Krka
  • Greece · Mempoglyn
  • Croatia · Mempoglyn
  • Hungary · Mempoglyn
  • Ireland · Empagliflozin/Metformin Krka
  • Iceland · Appref, Empagliflozin-Metformin Adalvo
  • Liechtenstein · Synjardy
  • Lithuania · Mempoglyn
  • Luxembourg · Empagliflozin/Metformin Hcl Ab
  • Latvia · Mempoglyn
  • Malta · Appref, Empagliflozin-Metformin Adalvo
  • Norway · Empagliflozin/Metformin Krka, Synjardy
  • Portugal · Empagliflozina + Metformina Aurobindo, Empagliflozina + Metformina Generis
  • Romania · Mempoglyn
  • Slovenia · Emameten, Empagliflozin/Metformin Krka

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e75a097b-1d8b-4a22-a44e-e824765cee41
GET /v1/drugs/e75a097b-1d8b-4a22-a44e-e824765cee41?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h134806_smpc.pdf",
  "strength": null,
  "atc_label": "Metformin and empagliflozin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg134806",
  "excipients": [
    "CALCIUMCARBONAAT (E 170)",
    "HYDROXYPROPYLCELLULOSE, LAAG GESUBSTITUEERD (E 463a)",
    "HYPROLOSE (E 463)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "MACROGOL 3350",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POLYVINYLALCOHOL (E 1203)",
    "TALK (E 553b)"
  ],
  "substances": [
    "EMPAGLIFLOZINE",
    "METFORMINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h134806.pdf",
  "authorised_at": "2026/04/20",
  "procedure_number": "SI/H/0347/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "134806",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about metformin and empagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console